IRIS
GAIDANO, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 25.692
NA - Nord America 24.091
AS - Asia 15.263
SA - Sud America 2.702
AF - Africa 447
Continente sconosciuto - Info sul continente non disponibili 73
OC - Oceania 38
Totale 68.306
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.542
RU - Federazione Russa 7.041
IE - Irlanda 5.575
SG - Singapore 4.826
CN - Cina 3.609
DE - Germania 2.938
HK - Hong Kong 2.900
SE - Svezia 2.683
UA - Ucraina 2.211
BR - Brasile 2.066
VN - Vietnam 1.829
IT - Italia 1.790
FI - Finlandia 1.194
FR - Francia 951
GB - Regno Unito 591
IN - India 478
BD - Bangladesh 362
KR - Corea 337
CA - Canada 282
AR - Argentina 256
MX - Messico 179
ID - Indonesia 145
ZA - Sudafrica 140
NL - Olanda 117
PL - Polonia 108
IQ - Iraq 106
JP - Giappone 106
BJ - Benin 103
EC - Ecuador 100
TR - Turchia 91
ES - Italia 82
AT - Austria 76
CO - Colombia 73
EU - Europa 70
IR - Iran 70
VE - Venezuela 62
BE - Belgio 61
CZ - Repubblica Ceca 56
LT - Lituania 55
PK - Pakistan 52
PY - Paraguay 50
CL - Cile 39
EG - Egitto 35
SA - Arabia Saudita 35
MA - Marocco 32
MY - Malesia 31
UZ - Uzbekistan 31
DZ - Algeria 30
KE - Kenya 30
PH - Filippine 30
PE - Perù 29
AU - Australia 27
SY - Repubblica araba siriana 26
MD - Moldavia 25
TN - Tunisia 21
IL - Israele 18
TW - Taiwan 18
BG - Bulgaria 17
ET - Etiopia 16
JO - Giordania 16
RO - Romania 16
AE - Emirati Arabi Uniti 15
JM - Giamaica 15
KZ - Kazakistan 15
DO - Repubblica Dominicana 14
UY - Uruguay 14
AZ - Azerbaigian 13
CH - Svizzera 13
CR - Costa Rica 13
NP - Nepal 12
OM - Oman 12
TH - Thailandia 12
AL - Albania 11
DK - Danimarca 11
KG - Kirghizistan 10
RS - Serbia 10
LB - Libano 9
NZ - Nuova Zelanda 9
TT - Trinidad e Tobago 9
BO - Bolivia 8
GR - Grecia 8
HR - Croazia 8
NG - Nigeria 8
PA - Panama 8
BH - Bahrain 7
HN - Honduras 7
PT - Portogallo 7
CY - Cipro 6
GE - Georgia 6
NI - Nicaragua 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
AO - Angola 5
CI - Costa d'Avorio 5
HU - Ungheria 5
MK - Macedonia 5
PS - Palestinian Territory 5
SI - Slovenia 5
AM - Armenia 4
BB - Barbados 4
Totale 68.231
Salva come PNG Salva come JPEG
Città #
Dublin 5.559
Jacksonville 3.933
Hong Kong 2.892
San Jose 2.326
Singapore 2.020
Dearborn 1.870
Ashburn 1.425
Chandler 1.334
Wilmington 1.278
Beijing 1.068
Moscow 948
Lawrence 733
Princeton 733
Lauterbourg 710
Los Angeles 597
Ho Chi Minh City 587
San Mateo 564
Council Bluffs 489
Hanoi 400
Buffalo 391
Andover 379
Piemonte 371
Seoul 315
Boardman 313
Ann Arbor 301
New York 274
Houston 213
Woodbridge 200
São Paulo 197
Dallas 184
Santa Clara 170
Novara 166
Orem 154
Hefei 145
Munich 143
Redondo Beach 142
Frankfurt am Main 122
Philadelphia 121
Guangzhou 117
Düsseldorf 115
Helsinki 112
Nanjing 112
Cotonou 103
Bremen 102
Milan 99
Kunming 98
Mexico City 97
Chennai 93
Norwalk 91
Tokyo 90
Warsaw 89
Montreal 87
London 86
Toronto 83
Nuremberg 82
Da Nang 80
Grafing 80
Tianjin 80
Columbus 78
Atlanta 76
Denver 75
Haiphong 74
Johannesburg 74
Brooklyn 71
St Louis 71
Chicago 69
Hangzhou 67
Rio de Janeiro 66
Poplar 63
Phoenix 62
Rome 62
Falkenstein 61
Turin 58
Seattle 57
Stockholm 55
Brussels 54
Jinan 54
Manchester 54
Amsterdam 53
Fairfield 50
Mumbai 47
Curitiba 45
Belo Horizonte 44
Shanghai 44
Nanchang 42
Brno 41
Jakarta 40
San Francisco 40
Vercelli 40
Boston 39
Brasília 39
Biên Hòa 36
Vienna 35
Porto Alegre 34
Quito 33
Baghdad 32
Guayaquil 32
Thái Bình 32
Dhaka 31
Hillsboro 30
Totale 37.823
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 257
Comparative Analysis of the Performance of Automated Digital Cell Morphology Analyzers for Leukocyte Differentiation in Hematologic Malignancies: Mindray MC‐80 Versus West Medical Vision Hema 234
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 233
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 200
Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities 193
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 180
Benefit sharing and globalisation of industry sponsored clinical trials for breast cancer research 178
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 177
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 175
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 175
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 173
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 172
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 170
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 165
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment 155
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 151
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 150
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 150
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 148
6q DELETIONS DEFINE DISTINCT CLINICO-PATHOLOGIC SUBSETS OF NON-HODGKIN'S LYMPHOMA 147
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 146
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 145
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 144
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome 141
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 141
A ROLE FOR GROWTH HORMONE AND PROLACTIN IN LEUKAEMIA AND LYMPHOMA? 140
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 140
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement 138
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 138
IL LINFOMA PRIMITIVO DELLE SIEROSE E ALTRE MALATTIE LINFOPROLIFERATIVE ASSOCIATE AD HHV-8 138
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 137
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 137
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 136
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 135
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 135
Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A 135
SIMIAN AIDS-RELATED LYMPHOMA GROWTH IN SCID MICE IS INDEPENDENT OF KARYOTYPIC ABNORMALITIES OR BCL-6 MUTATIONS 134
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 134
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 134
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 133
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 133
The clinical implications of gene mutations in chronic lymphocytic leukaemia 133
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 133
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 133
Factor VIII as a potential player in cancer pathophysiology 133
Targeting p53 in chronic lymphocytic leukemia 132
ANALYSIS OF HUMAN HERPESVIRUS TYPE-8 INFECTION IN AIDS-RELATED AND AIDS-UNRELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA 131
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 131
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 131
CLINICAL IMPLICATIONS OF THE MOLECULAR GENETICS OF CHRONIC LYMPHOCYTIC LEUKEMIA 131
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 130
A NEW TAQ I POLYMORPHISM IN THE p53 GENE 129
Absence of NOTCH1 gene mutations in MALT lymphomas 129
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 129
Genetic predisposition to myelodysplastic syndromes: A challenge for adult hematologists 129
A 2-Mb YAC CONTIG LINKING THE PLASMINOGEN-APOPROTEIN(a) GENE FAMILY TO THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR (IGF2R) GENE ON THE TELOMERIC REGION OF CHROMOSOME 6 (6q26-q27) 128
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 128
DIAGNOSI E CLASSIFICAZIONE DEI LINFOMI NON-HODGKIN. BASI PATOLOGICHE, FENOTIPICHE E MOLECOLARI 126
Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands 126
Libro universitario: Letteratura, medicina e scienze sociali. Convergenze tra culture e linguaggi; Chapter- Per un’etica della condivisione dei benefici in tema di sperimentazione dei farmaci 126
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 125
HUMAN NORMAL CD5+ B LYMPHOCYTES CAN BE INDUCED TO DIFFERENTIATE TO CD5- B LYMPHOCYTES WITH GERMINAL CENTER CELL FEATURES 124
AIDS ASSOCIATED LYMPHOMAS ARE EFFICIENTLY LYSED THROUGH COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) BY RITUXIMAB 123
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 123
The genetics of nodal marginal zone lymphoma 123
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study 123
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 123
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 122
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 122
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 122
ASSOCIATION OF KSHV POSITIVE PRIMARY EFFUSION LYMPHOMA WITH EXPRESSION OF THE CD138/SYNDECAN-1 ANTIGEN 121
LINFOMI NON-HODGKIN (NHL) E LINFOMA DI HODGKIN (HD) ASSOCIATI ALL'INFEZIONE DA HIV. CARATTERISTICHE EPIDEMIOLOGICHE, PATOLOGICHE, MOLECOLARI E CLINICHE NELL'ERA DELL'HAART 121
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 121
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 121
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 121
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 121
STRUCTURAL AND FUNCTIONAL ANALYSIS OF ONCOGENES AND TUMOR SUPPRESSOR GENES IN ADULT T-CELL LEUKEMIA/LYMPHOMA SHOWS FREQUENT p53 MUTATIONS 120
An anomalous case of acute coronary syndrome: the unexpected autoimmune duo 120
Biology and treatment of Richter syndrome 120
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation 120
EXPRESSION OF MUM-1/IRF4 SELECTIVELY CLUSTERS WITH PRIMARY EFFUSION LYMPHOMA AMONG LYMPHOMATOUS EFFUSIONS. IMPLICATIONS FOR DISEASE HISTOGENESIS AND PATHOGENESIS 119
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 119
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 119
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 119
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 119
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 119
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 119
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 119
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 118
MOLECULAR PATHOGENESIS OF NON-HODGKIN LYMPHOMA: A CLINICAL PERSPECTIVE 117
PATTERNS OF CYTOKINE EXPRESSION IN AIDS-RELATED NON-HODGKIN'S LYMPHOMA 117
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia 117
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 116
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group 116
GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA CHEMO-REFRACTORINESS 116
Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients 116
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 116
Chromosome 1 abnormalities in newly diagnosed elderly multiple myeloma patients treated with novel therapies. 115
MOLECULAR INVESTIGATION OF THE CYTOKINES PRODUCED BY NORMAL AND MALIGNANT B LYMPHOCYTES 115
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 115
Totale 13.727
Salva come PNG Salva come JPEG
Categoria #
all - tutte 355.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 355.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021141 0 0 0 0 0 0 0 0 0 0 0 141
2021/20224.996 122 26 992 587 342 78 488 117 325 140 805 974
2022/202310.113 807 313 461 399 575 833 201 459 5.554 29 298 184
2023/20243.104 241 214 246 76 585 50 630 78 23 41 215 705
2024/20258.283 182 63 257 173 245 473 646 843 2.767 882 332 1.420
2025/202627.125 1.029 893 2.116 3.717 1.947 2.021 4.094 4.696 2.289 2.232 1.450 641
Totale 69.176